Abstract Presentation

Change in Spinal Bone Mineral Density as estimated by Hounsfield Units following Osteoporosis Treatment with Romosozumab, Teriparatide, Denosumab, and Alendronate: An Analysis of 307 Patients

Presenting Author(s)

• 

  Anthony L. Mikula, MD

  Resident
  Mayo Clinic Department of Neurologic Surgery
  Rochester, MN, US

  Disclosure(s): No financial relationships to disclose